VaxInnate Corporation
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
Published in Malaria Weekly, May 18th, 2009
VaxInnate Corporation, a biotechnology company pioneering breakthrough technology that could dramatically improve the potency, manufacturing capacity and cost effectiveness of vaccines, announced the closing of $30 million in new Series D financing, led by its newest investor, The Wellcome Trust. New Leaf Venture Partners, Canaan Partners, HealthCare Ventures, Oxford Bioscience Partners, MedImmune Ventures and CHL Medical Ventures, representing all existing shareholders, also participated in the financing.
The funds will be used for the development of the company’s vaccines for infectious diseases that include influenza, human papillomavirus (HPV), respiratory syncytial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Malaria Weekly
Source: Malaria Weekly (2009-05-18)
More Articles from Malaria Weekly
- Apoptosis
Researchers from Fudan University report on findings in apoptosis - Cerebral Malaria
Data from Innsbruck Medical University provide new insights into cerebral malaria - Epidemics
New data from D.H. Mueller et al illuminate research in epidemics - Falciparum Malaria
Findings from College of Medicine in falciparum malaria reported - Falciparum Malaria
New falciparum malaria study results from Mahidol University described - Falciparum Malaria
Reports outline falciparum malaria study findings from A. Nasr and colleagues - More from this issue of Malaria Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
